SCHEMBL4666599

SCHEMBL4666599

CCc1cccc(-c2cc(Nc3ccccc3C(=O)OC)n(-c3cnccc3C)n2)c1

nearest known ligand 0.41

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.41
HPGD P15428 3/20 0.41
KDM4E B2RXH2 3/20 0.40
MAPT P10636 3/20 0.40
HSD17B10 Q99714 2/20 0.39
TSHR P16473 1/20 0.39
KMT2A Q03164 1/20 0.39
TP53 P04637 4/20 0.39
DGAT2 Q96PD7 1/20 0.37
GFER P55789 1/20 0.36
ADORA1 P30542 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4666522 0.92 KDM4C (0.43) ALDH1A1KDM4EMAPTTP53GFER
SCHEMBL4665751 0.87 HPGD (0.43) ALDH1A1HPGDKDM4EMAPTHSD17B10
SCHEMBL14600210 0.85 DHODH (0.45) MAPTTP53ADORA1
SCHEMBL14600476 0.85 KDM4C (0.43) ALDH1A1KDM4EMAPTTP53GFER
SCHEMBL14600212 0.84 KDM4C (0.38) ALDH1A1KDM4EMAPTTP53ADORA1
SCHEMBL14600664 0.80 HPGD (0.44) ALDH1A1HPGDKDM4EMAPTKMT2A
SCHEMBL4668570 0.79 GFER (0.42) KDM4EMAPTKMT2ATP53GFER
SCHEMBL14600270 0.78 GFER (0.42) MAPTKMT2ATP53GFERADORA1
SCHEMBL14600268 0.78 ADORA1 (0.42) MAPTTP53GFERADORA1
Hydrochloric Acid SCHEMBL4669539 0.78 GFER (0.41) KDM4EMAPTKMT2ATP53GFER

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1928455-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES Bayer Healthcare, LLC (US) 2008-06-11 EP disclosed
WO-2007027842-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES BAYER HEALTHCARE LLC (US) 2007-03-08 WO disclosed
WO-2007027842-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES BAYER HEALTHCARE LLC (US) 2007-03-08 WO disclosed